Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 47Y5M | — |
administered Infanrix to adult patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 68-year-old female patient who received DTPa (Infanrix) (batch number 47Y5M, expiry date 06-JUN-2026) for prophylaxis. On 14-APR-2025, the patient received Infanrix. On 14-APR-2025, an unknown time after receiving Infanrix, the patient experienced adult use of a child product (Verbatim: administered Infanrix to adult patient). The outcome of the adult use of a child product was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-APR-2025 The reporter administered DTAP instead of TDAP to an adult female patient, which led to adult use of a child product.